Dr Lal PathLabs Q1 net profit dips 57 per cent to ₹58 cr

PTI Updated - July 28, 2022 at 04:11 PM.

Dr Lal PathLabs board has declared an interim dividend of ₹6 per share for the current fiscal

Diagnostic services provider Dr Lal Path Labs on Thursday said its consolidated net profit declined 57 per cent to ₹58 crore for the first quarter ended June 30, 2022.

The company had reported a net profit of ₹134 crore in the April-June period of the last fiscal.

Revenue from operations declined to ₹503 crore in the period from ₹607 crore a year ago, Dr Lal PathLabs said in a regulatory filing.

The company's board has also declared an interim dividend of ₹6 per share for the current fiscal.

Sign up for newsletters, unlock features and do more on The Hindu
LOG IN
Support our reporting.
SUBSCRIBE NOW

Shares of the company were trading 1.27 per cent down at ₹2,142.7 apiece on BSE.

Published on July 28, 2022 10:41
Tags

This is a Premium article available exclusively to our subscribers.

Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

Subscribe
If you're already a subscriber
Access just this article

You have reached your free article limit.

Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

Subscribe
If you're already a subscriber
Access just this article

You have reached your free article limit.
Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

Subscribe
or read this article by Downloading TheHindu Businessline News app
If you're already a subscriber
Access just this article

TheHindu Businessline operates by its editorial values to provide you quality journalism.

Support our reporting.
Subscribe
This is your last free article.
to read unlimited content from TheHindu Businessline
Subscribe
Stay updated on Markets,Economy, Agri & more.
Get TheHindu Businessline News App on
Recommended Articles